Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
23.3M
-
Shares change
-
+2.89M
-
Total reported value, excl. options
-
$646M
-
Value change
-
+$80.3M
-
Number of buys
-
20
-
Number of sells
-
-13
-
Price
-
$27.76
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q2 2017
40 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q2 2017.
Ascendis Pharma A/S - ADR (ASND) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.3M shares
of 55.6M outstanding shares and own 41.87% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (5.58M shares), ORBIMED ADVISORS LLC (3.37M shares), FMR LLC (3.24M shares), Vivo Capital, LLC (1.77M shares), BAKER BROS. ADVISORS LP (1.75M shares), EcoR1 Capital, LLC (1.48M shares), venBio Select Advisor LLC (991K shares), VHCP Management II, LLC (986K shares), ACUTA CAPITAL PARTNERS, LLC (924K shares), and EVENTIDE ASSET MANAGEMENT, LLC (640K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.